+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Matrix metalloproteinases: pro- and anti-angiogenic activities



Matrix metalloproteinases: pro- and anti-angiogenic activities



Journal of Investigative Dermatology. Symposium Proceedings 5(1): 47-54



Matrix metalloproteinases (MMP) are a family of structurally related proteinases most widely recognized for their ability to degrade extracellular matrix, although recent investigations have demonstrated other biologic functions for these enzymes. MMP are typically not constitutively expressed, but are regulated by: (1) cytokines, growth factors, and cell-cell and cell-matrix interactions that control gene expression; (2) activation of their proenzyme form; and (3) the presence of MMP inhibitors [tissue inhibitors of metalloproteinases, (TIMP)]. MMP have important roles in normal processes including development, wound healing, mammary gland, and uterine involution, but are also involved in angiogenesis, tumor growth, and metastasis. Angiogenesis, characteristically defined as the establishment of new vessels from pre-existing vasculature, is required for biologic processes such as wound healing and pathologic processes such as arthritis, tumor growth, and metastasis. Blocking of MMP activity has been studied for potential therapeutic efficacy in controlling such pathologic processes. Synthetic MMP inhibitors, most notably the hydroxymates, have been engineered for this purpose and are presently in clinical trial. These inhibitors may have broad versus specific MMP inhibitory activity. As increased non-matrix degrading capabilities of MMP are recognized, however, i.e., cytokine activation, processing of proteins to molecules of distinct biologic function, it becomes less clear whether the nonselective inhibition of MMP activity for all pathologic processes involving MMP is appropriate. This review focuses upon the contribution of MMP to the process of tumor invasion and angiogenesis, and discusses the design and use of MMP inhibitors as therapeutic agents in these processes.

(PDF emailed within 0-6 h: $19.90)

Accession: 046631415

Download citation: RISBibTeXText

PMID: 11147675

DOI: 10.1046/j.1087-0024.2000.00004.x


Related references

Paeonol exerts anti-angiogenic and anti-metastatic activities through downmodulation of Akt activation and inactivation of matrix metalloproteinases. Biological & Pharmaceutical Bulletin 32(7): 1142-1147, 2009

Roles of pro-angiogenic and anti-angiogenic factors as well as matrix metalloproteinases in healing of NSAID-induced small intestinal ulcers in rats. Life Sciences 93(12-14): 441-447, 2014

Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer. Thyroid 12(8): 655-662, 2002

The anti-angiogenic effect of halofuginone Inhibition of collagen type I tube formation, matrix metalloproteinase-2 activities and extracellular matrix deposition. Blood 96(11 Part 1): 34a, November 16, 2000

Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b. European Journal of Cancer 39(11): 1632-1641, July, 2003

Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats. Zhonghua Yi Xue Za Zhi 86(7): 472-475, 2006

S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Research 59(18): 4702-4708, 1999

Catalytic activity of Matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. International Journal of Cancer 129(8): 1826-1837, 2012

p53 and matrix metalloproteinases in rheumatoid arthritis: tip of an angiogenic iceberg?. Seminars in Arthritis and Rheumatism 31(5): 287-288, 2002

Protective effect of a Butea monosperma (Lam.) Taub. flowers extract against skin inflammation: antioxidant, anti-inflammatory and matrix metalloproteinases inhibitory activities. Journal of Ethnopharmacology 148(2): 537-543, 2014

Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. Journal of Neurology, Neurosurgery, and Psychiatry 81(6): 673-678, 2010

Regulation of matrix metalloproteinases , and tissue inhibitor of metalloproteinases by anti transforming growth factor-B antibodies, lutein and Polypodium leucotomos in dermal fibroblasts. Molecular & Cellular Proteomics 2(9): 928, September, 2003

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities. Experimental and Therapeutic Medicine 8(6): 1835-1840, 2014